This study demonstrated that the CSF and plasma Alzheimer’s disease biomarkers p-tau 181 and p-tau 217 represent a distinct type of neuritic pathology around Aβ plaques in App knock-in mouse models of Aβ amyloidosis. This evidence concerns the gene MAPT and Alzheimer disease.